GST : 27AEUPJ3828B1ZE

Call us now

08045475302

Send Inquiry

Request To Call Back

Bortether 3.5 mg

Name: Bortether 3.5 mg
Brand: DATTATRAYA MEDICAL & GENERAL STORES
Price: 500 INR
Availability: InStock

Price 500 INR/ Vial

Get a Price/Quote

MOQ : 10 Vials

Bortether 3.5 mg Specification

Dosage Form
Injection

Life Span
24 months from manufacture date

Origin of Medicine
India

Indication
Multiple Myeloma, Mantle Cell Lymphoma

Pacakaging (Quantity Per Box)
1 vial per box

Packaging Type
Glass vial with flip-off seal

Salt Composition
Bortezomib 3.5 mg

Brand Name
Bortether

Drug Type
Allopathic

Ingredients
Bortezomib

Physical Form
Lyophilized Powder for Injection

Function
Antineoplastic agent (proteasome inhibitor)

Recommended For
Adults with Multiple Myeloma or Mantle Cell Lymphoma

Dosage
As directed by physician; typically 1.3 mg/m2 body surface area

Dosage Guidelines
Use as prescribed by healthcare professional; intravenous or subcutaneous use only

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C, protect from light

Marketed By
Mylan

Side Effects
Peripheral neuropathy, thrombocytopenia, fatigue, nausea

Route of Administration
Intravenous or Subcutaneous

Color
White to off-white powder

ATC Code
L01XX32

Prescription Required
Yes

Contraindications
Hypersensitivity to bortezomib or boron

Schedule
Schedule H (Prescription Drug)

Reconstitution Required
Yes, with sterile normal saline solution

Bortether 3.5 mg Trade Information

Minimum Order Quantity
10 Vials

Payment Terms
Cash Advance (CA)

Supply Ability
5000 Vials Per Month

Delivery Time
5-7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

About Bortether 3.5 mg

Get It Now-Bortether 3.5 mg, a top-drawer antineoplastic agent, has garnered favorable reviews for its efficacy against Multiple Myeloma and Mantle Cell Lymphoma. Procure this majestic solution, uniquely formulated as a white to off-white lyophilized powder for injection. Manufactured in India and marketed by Mylan, this invincible therapy requires reconstitution with sterile saline and must be administered intravenously or subcutaneously by a healthcare professional. Prescription mandatory; schedule H restrictions apply. Each glass vial, with flip-off seal, contains Bortezomib 3.5 mg for reliable dosing.

Special Features and Applications of Bortether 3.5 mg

Bortether 3.5 mg is specifically designed for adult patients battling Multiple Myeloma and Mantle Cell Lymphoma. Its use type is prescribed-only, ensuring safe administration under medical guidance. Apart from hematologic malignancies, its powerful proteasome inhibitor action extends to experimental treatments in oncology. Special features include a long shelf life of 24 months, easy reconstitution, and reliable efficacy, making it a sought-after choice among healthcare professionals and exporters in India.

Packaging, Sample Policy & Supply Details of Bortether 3.5 mg

Packing & Dispatch of Bortether 3.5 mg is carried out with utmost care: each glass vial is securely sealed and boxed for optimal safety. Transportation logistics are streamlined to ensure that stock is ready and supplied efficiently to buyers worldwide. Sample policies may be available upon request, and robust supply ability ensures consistent availability without interruptions, backed by top-tier warehousing and distribution channels.

FAQ's of Bortether 3.5 mg:

Q: How is Bortether 3.5 mg administered?

A: Bortether 3.5 mg is administered either intravenously or subcutaneously, and must be reconstituted with sterile normal saline solution before use. Administration should only be performed by a healthcare professional.

Q: What conditions is Bortether 3.5 mg recommended for?

A: This medication is primarily recommended for adults diagnosed with Multiple Myeloma or Mantle Cell Lymphoma, as directed by a qualified physician.

Q: When should I seek medical advice while using Bortether 3.5 mg?

A: If you experience unexpected side effects such as severe peripheral neuropathy, thrombocytopenia, or any signs of allergic reaction, contact your healthcare provider immediately for guidance.

Q: Where should Bortether 3.5 mg be stored?

A: The vial should be stored below 25C, away from direct light. Always keep it in its original packaging until ready for use, following all storage recommendations provided by your pharmacist or healthcare provider.

Q: What is the process for reconstituting Bortether 3.5 mg?

A: Bortether 3.5 mg must be reconstituted by a healthcare professional using sterile normal saline as per the product guidelines, ensuring the powder fully dissolves before administration.

Q: How does Bortether 3.5 mg function in cancer treatment?

A: Bortether acts as a proteasome inhibitor, impeding protein degradation within cancer cells, thereby inhibiting tumor growth and enhancing the effectiveness of cancer therapies.

Tell us about your requirement